ADCT
Price
$2.75
Change
-$0.10 (-3.51%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
282.8M
48 days until earnings call
CLRB
Price
$7.94
Change
-$1.76 (-18.14%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
14.9M
54 days until earnings call
Interact to see
Advertisement

ADCT vs CLRB

Header iconADCT vs CLRB Comparison
Open Charts ADCT vs CLRBBanner chart's image
ADC Therapeutics SA
Price$2.75
Change-$0.10 (-3.51%)
Volume$6.6K
Capitalization282.8M
Cellectar Biosciences
Price$7.94
Change-$1.76 (-18.14%)
Volume$890
Capitalization14.9M
ADCT vs CLRB Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CLRB commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Buy and CLRB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ADCT: $2.85 vs. CLRB: $9.70)
Brand notoriety: ADCT and CLRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 116% vs. CLRB: 32%
Market capitalization -- ADCT: $282.8M vs. CLRB: $14.9M
ADCT [@Biotechnology] is valued at $282.8M. CLRB’s [@Biotechnology] market capitalization is $14.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileCLRB’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • CLRB’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while CLRB’s TA Score has 5 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 4 bearish.
  • CLRB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ADCT and CLRB are a good buy in the short-term.

Price Growth

ADCT (@Biotechnology) experienced а -12.58% price change this week, while CLRB (@Biotechnology) price change was -7.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

CLRB is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($283M) has a higher market cap than CLRB($14.9M). ADCT YTD gains are higher at: 43.216 vs. CLRB (8.138). CLRB has higher annual earnings (EBITDA): -45.92M vs. ADCT (-95.64M). CLRB has less debt than ADCT: CLRB (474K) vs ADCT (123M). ADCT has higher revenues than CLRB: ADCT (75.8M) vs CLRB (0).
ADCTCLRBADCT / CLRB
Capitalization283M14.9M1,899%
EBITDA-95.64M-45.92M208%
Gain YTD43.2168.138531%
P/E RatioN/AN/A-
Revenue75.8M0-
Total Cash195MN/A-
Total Debt123M474K25,949%
FUNDAMENTALS RATINGS
CLRB: Fundamental Ratings
CLRB
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCLRB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AI24.170.57
+2.42%
C3ai
CECO29.370.46
+1.59%
CECO Environmental Corp
CANF1.060.01
+1.44%
Can-Fite BioPharma Ltd
FTS47.37-0.21
-0.44%
Fortis
LANV2.09-0.06
-2.79%
Lanvin Group Holdings Limited

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+6.34%
QTTB - ADCT
48%
Loosely correlated
+3.92%
VTYX - ADCT
44%
Loosely correlated
+0.42%
IMNM - ADCT
41%
Loosely correlated
+2.06%
OVID - ADCT
40%
Loosely correlated
+4.03%
CLRB - ADCT
40%
Loosely correlated
+8.57%
More

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+8.57%
QTTB - CLRB
73%
Closely correlated
+3.92%
IBRX - CLRB
42%
Loosely correlated
+1.09%
ADCT - CLRB
39%
Loosely correlated
+6.34%
ANAB - CLRB
37%
Loosely correlated
+2.19%
CELC - CLRB
37%
Loosely correlated
+6.11%
More